1. Home
  2. AORT vs OLMA Comparison

AORT vs OLMA Comparison

Compare AORT & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$24.04

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Olema Pharmaceuticals Inc.

OLMA

Olema Pharmaceuticals Inc.

HOLD

Current Price

$11.83

Market Cap

994.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AORT
OLMA
Founded
1984
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
994.9M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
AORT
OLMA
Price
$24.04
$11.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
10
Target Price
$49.40
$44.89
AVG Volume (30 Days)
763.4K
1.9M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
165.62
15.00
EPS
0.03
N/A
Revenue
$298,836,000.00
N/A
Revenue This Year
$14.20
N/A
Revenue Next Year
$11.20
N/A
P/E Ratio
$773.67
N/A
Revenue Growth
18.01
N/A
52 Week Low
$19.16
$4.37
52 Week High
$48.25
$36.26

Technical Indicators

Market Signals
Indicator
AORT
OLMA
Relative Strength Index (RSI) 54.70 50.55
Support Level $19.49 $7.79
Resistance Level $25.04 $13.09
Average True Range (ATR) 1.12 0.69
MACD 0.25 0.09
Stochastic Oscillator 69.03 39.30

Price Performance

Historical Comparison
AORT
OLMA

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Share on Social Networks: